During the past decade, Ilker Şengül conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ilker Şengül" are "Adhesive Capsulitis of the Shoulder" (1 trials), "Hemiplegia" (1 trials), "Hemiplegia, Spastic" (1 trials), "Muscle Spasticity" (1 trials) and "Partial Thickness Rotator Cuff Tear" (1 trials). Many other conditions were trialed in "Ilker Şengül" in a lesser frequency.

Most popular intervention types in "Ilker Şengül" are "Combination Product" (1 trials), "Device" (1 trials), "Diagnostic Test" (1 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Australian Spasticity Assessment Scale" (1 trials), "Botulinum toxin type A" (1 trials), "Imaging" (1 trials), "Multimodal physical therapy with exercise" (1 trials) and "Repetitive transcranial magnetic stimulation" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ilker Şengül" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Ilker Şengül". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Ilker Şengül, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ilker Şengül, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".